Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands.

Kristalijn SA, White K, Eerbeek D, Kostenko E, Grati FR, Bilardo CM. BMC Pregnancy Childbirth. 2022;22(1):782. Published 2022 Oct 20. doi:10.1186/s12884-022-05110-2. Open Access: Learn more

Tags: Patient Perspectives, 2022, Netherlands, RAAs, CNVs

  • Study used online questionnaires and semi-structured interviews. 4539 questionnaire responses were analyzed; 60% of respondents had experienced NIPT.
  • “Conclusions: The patient experience with first-tier NIPT in the Netherlands was largely positive. Areas for improvement included counseling on the implications of screening and the different possible outcomes of NIPT, including additional findings that may be uncovered by expanding NIPT beyond the common trisomies.”